Detalles de la búsqueda
1.
The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
Osteoporos Int
; 35(2): 255-263, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37798320
2.
Primary hyperparathyroidism in adults-(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society.
Clin Endocrinol (Oxf)
; 2021 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34927274
3.
Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society.
Clin Endocrinol (Oxf)
; 2021 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34931708
4.
Reduced Bone Modeling and Unbalanced Bone Remodeling: Targets for Antiresorptive and Anabolic Therapy.
Handb Exp Pharmacol
; 262: 423-450, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32232792
5.
Correction to: The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
Osteoporos Int
; 35(2): 371, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37940698
6.
Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: position statement summary.
Med J Aust
; 211(5): 224-229, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31318068
7.
Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia.
Clin Endocrinol (Oxf)
; 89(3): 280-296, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29741296
8.
The Influence of Cortical Porosity on the Strength of Bone During Growth and Advancing Age.
Curr Osteoporos Rep
; 16(5): 561-572, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30187285
9.
Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?
Clin Endocrinol (Oxf)
; 85(5): 689-693, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27497423
10.
Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis.
J Clin Endocrinol Metab
; 109(2): 303-311, 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37610985
11.
Cardiometabolic Effects of Denosumab in Premenopausal Women with Breast Cancer Receiving Estradiol Suppression: RCT.
J Clin Endocrinol Metab
; 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181438
12.
The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.
J Bone Miner Res
; 38(1): 26-34, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36333954
13.
Protocol: Can coronary artery calcium score identified on thoracic planning CT scans be used and actioned to identify cancer survivors at high risk of cardiac events: A feasibility study in cancer survivors undergoing radiotherapy in Australia.
BMJ Open
; 13(7): e072376, 2023 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463809
14.
Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension.
J Bone Miner Res
; 36(5): 921-930, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33507574
15.
Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.
J Bone Miner Res
; 36(1): 41-51, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32790196
16.
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT.
J Clin Endocrinol Metab
; 105(3)2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31674641
17.
The effects of adjuvant endocrine therapy on bone health in women with breast cancer.
J Endocrinol
; 241(3): R111-R124, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30991355
18.
Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer.
J Endocr Soc
; 3(7): 1283-1301, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31259291
19.
Advances and Unmet Needs in the Therapeutics of Bone Fragility.
Front Endocrinol (Lausanne)
; 9: 505, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30237785
20.
Higher maternal serum prolactin levels are associated with reduced glucose tolerance during pregnancy.
J Diabetes Investig
; 8(5): 697-700, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28129477